A Rockville gene therapy company is determined to find a cure for HIV — and recent studies suggest it might be on the right track.
American Gene Technologies, a 15-year-old company founded and run by CEO Jeff Galvin, conducted several clinical trials with “strong, positive results” indicating a potential cure for patients diagnosed with human immunodeficiency virus (HIV), which leads to AIDS. American Gene is now creating a separate company called Addimmune to focus solely on HIV research and trials.
“We are confident that we’re on course for an HIV cure,” Galvin said. “Addimmune can focus all its efforts on HIV, while American Gene continues to explore gene therapy cures for other diseases.” [WTOP]